ArticleNaunyn-Schmiedeberg's archives of pharmacology2026
Global trends and knowledge mapping of steroid-resistant nephrotic syndrome research: a bibliometric analysis.
Article in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Steroid-resistant nephrotic syndrome (SRNS) is a major cause of kidney failure and remains a clinical challenge. Bibliometric analysis offers a quantitative approach to reveal research patterns and hotspots, yet, to our knowledge, no bibliometric analysis has focused specifically on SRNS. To summarize global research trends and future directions in SRNS. Publications related to SRNS from 1 January 1999 to 14 June 2026 were retrieved from the Web of Science Core Collection (WoSCC) database. Bibliometric analyses were performed using VOSviewer, CiteSpace, and RStudio. A total of 1,720 eligible articles and reviews from 91 countries were included. Annual publication output increased overall, although the 2026 data represented an incomplete year. The United States ranked first in both publications and citations; the University of Michigan, Friedhelm Hildebrandt, and Pediatric Nephrology were the most productive institution, author, and journal, respectively. Keyword analysis showed a transition from podocyte proteins and gene mutations toward multicenter cohorts, genetic testing, kidney transplantation, variants, and chronic kidney disease. The three most frequently co-cited references were Sadowski et al. (2015), Boute et al. (2000), and Ruf et al. (2004). This study maps the global SRNS literature and identifies major research trends and emerging themes, providing a reference for investigations into the pathogenesis, diagnosis, and treatment of SRNS.
Indexed as
Identifiers
42680870What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.